PT-INR Calculator — International Normalized Ratio from Prothrombin Time
Calculate the International Normalized Ratio (INR) from prothrombin time (PT) and ISI to monitor warfarin therapy, coagulation status, and liver function.
PT-INR Calculator
Enter values below to calculate
Patient's measured PT from lab report.
Lab's mean normal PT. Typically 11–13s. Check your lab report.
ISI of your lab's thromboplastin reagent. Usually 1.0–1.4. Most modern labs use ISI close to 1.0.
This calculator is for informational and educational purposes. Results should be interpreted with clinical judgment and local guidelines.
What is PT-INR (International Normalized Ratio)?
The International Normalized Ratio (INR) is the globally standardized expression of prothrombin time (PT), designed to allow consistent comparison of coagulation results across different laboratories and thromboplastin reagents. Before INR standardization, PT results varied significantly between labs using different reagents, making monitoring of oral anticoagulant therapy unreliable. The INR is calculated from the patient's prothrombin time, the mean normal prothrombin time of the laboratory's reference population, and the International Sensitivity Index (ISI) of the thromboplastin reagent used. A normal INR in a non-anticoagulated patient is 0.8–1.2. In patients on warfarin therapy for atrial fibrillation or venous thromboembolism, the target therapeutic range is typically 2.0–3.0. Patients with mechanical heart valves require a higher target of 2.5–3.5.
INR = (PT patient / PT normal)^ISI. Normal INR: 0.8–1.2. Warfarin therapeutic range (AF/DVT/PE): 2.0–3.0. Mechanical heart valve: 2.5–3.5. Critical bleeding risk: INR > 5.0.
When to Use the PT-INR Calculator
- Monitoring warfarin (Coumadin) anticoagulation therapy in patients with atrial fibrillation, venous thromboembolism (DVT/PE), mechanical heart valves, or antiphospholipid syndrome requiring target INR ranges.
- Pre-operative coagulation assessment to evaluate bleeding risk before elective or emergency surgical procedures. Most surgeries require INR < 1.5 (corrected to < 1.2 for high-bleeding-risk procedures).
- Liver function assessment: PT/INR is a component of the Child-Pugh and MELD scores. Elevated INR in a non-anticoagulated patient indicates hepatic synthetic dysfunction.
- Assessment of vitamin K deficiency, warfarin toxicity, or over-anticoagulation requiring reversal with vitamin K, fresh frozen plasma (FFP), or 4-factor prothrombin complex concentrate (4F-PCC).
- Evaluation of disseminated intravascular coagulation (DIC), inherited coagulation factor deficiencies (Factors II, V, VII, X), or drug-induced coagulopathy.
- Point-of-care INR testing for home warfarin self-monitoring using portable coagulometers (CoaguChek, INRatio) in anticoagulation clinics.
PT-INR Formula & ISI Standardization
INR Calculation Formula
INR = (PT patient / PT mean normal)^ISI
PT patient = 28s, PT normal = 12s, ISI = 1.0 → INR = (28/12)^1.0 = 2.33
With ISI Adjustment
INR = (PT patient / PT normal)^ISI where ISI is specific to the thromboplastin reagent
PT patient = 28s, PT normal = 12s, ISI = 1.2 → INR = (28/12)^1.2 = 2.61
Variables
PT patient (seconds)
Patient's prothrombin time measured in seconds. Normal range: 11–13.5 seconds (varies by lab). Report from current laboratory test.
PT normal (MNPT) (seconds)
Mean Normal Prothrombin Time of the laboratory's reference population. Typically 11–12 seconds. This value is lab-specific; check your lab's report.
ISI (International Sensitivity Index) (dimensionless)
ISI calibrates the thromboplastin reagent used. Closer to 1.0 = more responsive reagent. Most modern labs use ISI 1.0–1.4. The ISI value is provided by the reagent manufacturer and laboratory.
Most clinical laboratories automatically calculate and report INR directly from PT. This calculator is useful when converting PT from a point-of-care device or when comparing results from different laboratories. Always use the ISI value specific to your laboratory's current thromboplastin reagent.
INR Interpretation & Clinical Management
INR interpretation depends on clinical context: whether the patient is on anticoagulation therapy, the indication for anticoagulation, and the clinical scenario (bleeding vs. thrombosis risk).
| Range | Classification | Health Risk |
|---|---|---|
| 0.8–1.2 | Normal (Non-anticoagulated) | Normal coagulation. No therapy adjustment needed. |
| 1.5–2.0 | Sub-therapeutic | Below target for most warfarin indications. Increase warfarin dose; recheck INR in 3–5 days. |
| 2.0–3.0 | Therapeutic Range (Standard) | Target for AF, DVT/PE, bioprosthetic valve. Maintain current dose; recheck in 4 weeks. |
| 2.5–3.5 | Therapeutic Range (High-Intensity) | Target for mechanical mitral valve, high-risk valve prostheses. Maintain current dose. |
| 3.0–5.0 | Supra-therapeutic | Elevated bleeding risk. Hold 1–2 doses, recheck INR in 2–3 days. Consider vitamin K 1–2.5mg oral if bleeding present. |
| > 5.0 | Critically Elevated — Bleeding Risk | High bleeding risk. Hold warfarin. Vitamin K 2.5–5mg oral or IV. If active/serious bleeding: 4F-PCC or FFP + Vitamin K 10mg IV. |
| > 8.0 | Dangerously Elevated — Emergency | Emergency reversal required. 4F-PCC (Beriplex/Octaplex) + Vitamin K 10mg slow IV. ICU/Emergency admission. |
Target INR ranges are indication-specific. Always verify the therapeutic target against the patient's specific anticoagulation indication. INR stability (time in therapeutic range, TTR) over multiple readings is a better predictor of anticoagulation quality than any single INR value.
PT-INR Calculator Limitations & Clinical Warnings
INR is standardized for monitoring vitamin K antagonists (warfarin, acenocoumarol, phenprocoumon) ONLY. INR is NOT used to monitor direct oral anticoagulants (DOACs: dabigatran, rivaroxaban, apixaban, edoxaban) — DOACs have variable PT effects.
ISI must be lab-specific: The ISI value varies by reagent brand and lot. Using an incorrect ISI produces an inaccurate INR. Always use the ISI provided by your laboratory.
Point-of-care (POC) vs laboratory INR: POC coagulometers (CoaguChek XS) use different methodology and may differ from central lab INR by ±0.4 units. Consider confirmatory lab INR before major dose changes.
Lupus anticoagulant: Patients with antiphospholipid antibodies may have falsely prolonged PT in some assays, making INR unreliable. Chromogenic anti-Factor Xa levels may be preferred for monitoring.
Hematocrit effect: Significant anemia (Hct < 25%) or polycythemia (Hct > 55%) affects PT-INR accuracy in citrated blood tubes due to altered anticoagulant-to-blood ratio. Request corrected tube fill.
Diet and drug interactions: Vitamin K-rich foods (leafy greens), antibiotics, amiodarone, NSAIDs, and many other drugs cause clinically significant INR fluctuations in warfarin patients.
Medical Disclaimer
PT-INR results must be reviewed in full clinical context by qualified medical personnel. Anticoagulation management requires assessment of bleeding history, drug interactions, dietary factors, and comorbidities. Emergency reversal of anticoagulation (INR > 5 with active bleeding) requires immediate medical intervention.
References & Citations
- Hirsh J, Fuster V, Ansell J, Halperin JL. “American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy”. Journal of the American College of Cardiology. 2003. 41(9): 1633–1652. PMID: 12742309 | DOI: 10.1016/S0735-1097(03)00347-9
- World Health Organization (WHO). “Use of Anticoagulants in Developing Countries: WHO Technical Report Series 889”. World Health Organization. 1999.. WHO Technical Report Series No. 889
- Keeling D, Baglin T, Tait C, et al.. “Guidelines on oral anticoagulation with warfarin — fourth edition”. British Journal of Haematology. 2011. 154(3): 311–324. PMID: 21671894 | DOI: 10.1111/j.1365-2141.2011.08753.x
- Ageno W, Gallus AS, Wittkowsky A, et al.. “Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: ACCP Guidelines”. Chest. 2012. 141(2 Suppl): e44S–88S. PMID: 22315269 | DOI: 10.1378/chest.11-2292
Medically Reviewed
Reviewed by CliniqWise Clinical Advisory Board — Hematology & Anticoagulation Panel · Last updated: 2026-08-27 · Next review: 2027-02-27
Common Questions About PT-INR Calculator
Explore More Medical Calculators
Browse the CliniqWise calculator library by specialty, score, disease area, or clinical task.
Browse All Calculators